Literature DB >> 9149045

Liver-spleen infarcts following transcatheter chemoembolization: a case report and review of the literature on adverse effects.

S E Cohen1, R Safadi, A Verstandig, A Eid, T Sasson, L Symmer, D Shouval.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9149045     DOI： 10.1023/a:1018816531421

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  23 in total

1.  Diagnostic value of Lipiodol injection in focal nodular hyperplasia of the liver.

Authors:  S Kondo; M Nishikawa; S Takami; T Fukuzaki; M Kurokawa; M Ohi; H Shimomukai; Y Matsuda; K Kuroda
Journal:  Am J Gastroenterol       Date:  1991-06       Impact factor: 10.864

2.  Transcatheter arterial embolization in unresectable hepatocellular carcinoma.

Authors:  R Yamada; K Kishi; T Sonomura; M Tsuda; S Nomura; M Satoh
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

3.  Lipiodol retention at the site of liver biopsy; a false positive result in the investigation of hepatocellular carcinoma.

Authors:  J E Jackson; E Y Yeung; P McCarthy; C Foster; I S Benjamin; A Adam
Journal:  Clin Radiol       Date:  1989-09       Impact factor: 2.350

4.  A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.

Authors:  G Pelletier; A Roche; O Ink; M L Anciaux; S Derhy; P Rougier; C Lenoir; P Attali; J P Etienne
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

5.  Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections.

Authors:  N Nagasue; G Galizia; H Kohno; Y C Chang; T Hayashi; A Yamanoi; T Nakamura; H Yukaya
Journal:  Surgery       Date:  1989-07       Impact factor: 3.982

6.  A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma.

Authors:  T Kanematsu; T Furuta; K Takenaka; T Matsumata; Y Yoshida; T Nishizaki; K Hasuo; K Sugimachi
Journal:  Hepatology       Date:  1989-07       Impact factor: 17.425

Review 7.  Treatment of small hepatocellular carcinomas.

Authors:  G M Dusheiko; K E Hobbs; R Dick; A K Burroughs
Journal:  Lancet       Date:  1992-08-01       Impact factor: 79.321

8.  Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis.

Authors:  E Adachi; T Matsumata; T Nishizaki; H Hashimoto; M Tsuneyoshi; K Sugimachi
Journal:  Cancer       Date:  1993-12-15       Impact factor: 6.860

9.  Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.

Authors:  J W Chung; J H Park; J K Han; B I Choi; M C Han; H S Lee; C Y Kim
Journal:  Radiology       Date:  1996-01       Impact factor: 11.105

10.  Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

Authors:  M V Madden; J E Krige; S Bailey; S J Beningfield; C Geddes; I D Werner; J Terblanche
Journal:  Gut       Date:  1993-11       Impact factor: 23.059
View more
  2 in total

1.  Liver abscess as a complication of hepatic transarterial chemoembolization: a case report, literature review, and clinical recommendations.

Authors:  Ari M Vanderwalde; Howard Marx; Lucille Leong
Journal:  Gastrointest Cancer Res       Date:  2009-11

2.  Hepatic infarction and acute pancreatitis: a case report and review of the literature.

Authors:  Archana Kulkarni; Hamza Arif; Manik Veer; Kateyln Ziggas; Amit Kaura; Meera Sareen
Journal:  Clin Exp Hepatol       Date:  2018-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.